Intraepithelial and stromal lymphocytes in the normal human prostate

被引:66
作者
Bostwick, DG
de la Roza, G
Dundore, P
Corica, FA
Iczkowski, KA
机构
[1] Mayo Clin & Mayo Fdn, Dept Pathol & Lab Med, Rochester, MN 55905 USA
[2] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA
关键词
prostate; inflammation; lymphocytes; immunology; prostatic neoplasms; epithelium;
D O I
10.1002/pros.10224
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
BACKGROUND. The distribution and significance of lymphocytes in the normal human prostate is uncertain. It may be important as a determinant of the immune response, playing a role in hyperplasia and carcinogenesis. METHODS. We studied 28 normal autopsy prostates from patients between 1 and 64 years of age. Cases with nodular hyperplasia, intraepithelial neoplasia, cancer, and florid prostatitis were excluded. Each prostate was routinely processed to paraffin and immunohistochemically stained for CD20, CD45, and CD45RO. Three frozen samples obtained from these cases were stained for CD8 and CD4. One low power field (25x magnification, 50 mm 2) was randomly chosen for examination from each anatomic zone of the prostate, namely the peripheral, transition, and central zone. Lymphocytes were visually counted in the stroma and epithelium of each zone. Lymphocyte counts were converted to number of cells per square millimeter based on the area of the slide per field and the percentage of field that was glandular. RESULTS. Stromal lymphocytes were more numerous than epithelial lymphocytes (mean, 7.32 and 2.04 cells/mm(2), respectively). They were mostly T cells (stromal lymphocytes: 93% CD45RO+; epithelial lymphocytes: 99% CD45RO+). Helper/inducer (CD4+) T cells predominated in the stroma, whereas those in epithelium were chiefly cytotoxic/suppressor (CD8+). No difference was found in the number of stromal and epithelial T or B cells according to patient age, race, or location within the prostate (peripheral, central, and transition zones) (all P > 0.05), although the number of lymphocytes in the peripheral zone tended to exceed that in the other zones after correcting for gland:stroma ratio. CONCLUSIONS. The immune response in the prostate is primarily cell-mediated. Cell distribution is constant according to patient age, race, and anatomic zonal location within the prostate. The greatest concentration is in the stroma with a small but significant number of intraepithelial cells. The inverted CD4/CD8 ratio in the intraepithelial compartment suggests that cytotoxic/suppressor T cells are the first line of defense against luminal foreign agents reaching the prostate through retrograde flow. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 30 条
[1]
IMMUNOSUPPRESSION OF CELL-MEDIATED AND SERUM-MEDIATED TUMOR-ASSOCIATED IMMUNITY IN PROSTATIC-CANCER BY HUMAN SEMINAL PLASMA [J].
ABLIN, RJ ;
BHATTI, RA ;
BUSH, IM ;
GUINAN, PD .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (06) :775-780
[2]
Bierhoff E, 1996, EUR UROL, V29, P345
[3]
THE ANATOMY OF THE PROSTATE - RELATIONSHIP WITH PROSTATIC INFECTION [J].
BLACKLOCK, NJ .
INFECTION, 1991, 19 :S111-S114
[4]
INCIDENTAL LYMPHOCYTIC PROSTATITIS - SELECTIVE INVOLVEMENT WITH NONMALIGNANT GLANDS [J].
BLUMENFELD, W ;
TUCCI, S ;
NARAYAN, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1992, 16 (10) :975-981
[5]
IMMUNOLOGICAL ALTERATIONS IN PATIENTS WITH PROSTATIC CARCINOMA [J].
BROSMAN, S ;
HAUSMAN, M ;
SHACKS, S .
JOURNAL OF UROLOGY, 1975, 113 (06) :841-845
[6]
EFFECT OF RADIATION-THERAPY FOR UROLOGIC CANCER ON CIRCULATING THYMUS-DERIVED LYMPHOCYTES [J].
CATALONA, WJ ;
POTVIN, C ;
CHRETIEN, PB .
JOURNAL OF UROLOGY, 1974, 112 (02) :261-267
[7]
EFFECTS OF CHEMOTHERAPY FOR PROSTATIC CARCINOMA ON T LYMPHOCYTE LEVELS [J].
CATALONA, WJ .
JOURNAL OF UROLOGY, 1974, 112 (06) :802-807
[8]
In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen [J].
Correale, P ;
Walmsley, K ;
Nieroda, C ;
Zaremba, S ;
Zhu, MZ ;
Schlom, J ;
Tsang, KY .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (04) :293-300
[9]
SKIN TESTING IN GENITOURINARY CARCINOMA - 2-YEAR FOLLOWUP [J].
DECENZO, JM ;
ALLISON, R ;
LEADBETTER, GW .
JOURNAL OF UROLOGY, 1975, 114 (02) :271-273
[10]
Elsässer-Beile U, 2000, PROSTATE, V45, P1, DOI 10.1002/1097-0045(20000915)45:1<1::AID-PROS1>3.0.CO